Skip to main content
. 2020 May 21;11(5):383. doi: 10.1038/s41419-020-2598-6

Fig. 2. High glucose mediated endothelial NLRP3 inflammasome activation via upregulation of MARK4 expression in HUVECs.

Fig. 2

a Interleukin (IL)-1β and IL-18 mRNA expression in normal and hyperglycaemic HUVECs. b Western blot analysis of NLRP3 inflammasome expression in normal and hyperglycaemic HUVECs. c The mRNA expression of NLRP3 inflammasome in normal and hyperglycaemic HUVECs. d Western blot analysis of MARK4 expression in normal and hyperglycaemic HUVECs. e The mRNA expression of MARK4 in normal and hyperglycaemic HUVECs. f The effects of siMARK4 on high glucose-induced NLRP3 inflammasome protein expression in hyperglycaemic HUVECs. g The effects of siMARK4 on high glucose-induced NLRP3 inflammasome mRNA expression in hyperglycaemic HUVECs. h The effects of siMARK4 on high glucose-induced IL-1β and IL-18 mRNA expression in hyperglycaemic HUVECs. (*P ≤ 0.001, **P ≤ 0.0001, compared with the control group; #P ≤ 0.001, ##P ≤ 0.0001, compared with the high glucose treatment group, n = 5/group).